Company Profile
Aedifica NV/SA is a Belgian public regulated real estate company specializing in European healthcare real estate, particularly properties for elderly care. Aedifica has built a real estate portfolio worth approximately 12.4 billion euros in Belgium, Germany, the Netherlands, the United Kingdom, Finland, Ireland, Spain, France, and Italy. Aedifica is listed on Euronext Brussels (2006) and Euronext Amsterdam (2019) and is identified by the following codes: AED; AED:BB (Bloomberg); AOO.BR (Reuters). Since 2020, Aedifica has been a constituent of the BEL 20, the main stock market index of Euronext Brussels. Furthermore, since 2023, Aedifica has been included in the BEL ESG, the index that tracks the best-performing companies based on ESG criteria. Aedifica is also included in the EPRA, Stoxx Europe 600, and GPR indices. Its market capitalization was approximately 6.5 billion euros as of July 1st, 2026. Aedifica NV/SA was established on November 07, 2005 and incorporated in 2005 in Belgium.
Latest News
Dreame Technology Redefines Hands-free Cleaning with the Launch of the Dreame D30 Ultra Robot Vacuum
Jiangxi Bio's Veterinary Tetanus Antitoxin Production Line Officially Commenced Production,Accelerating Commercialization of the Animal Antiserum Portfolio
Far-right Australian politician loses appeal in racism case
| Sector | Real Estate |
| Industry | REIT - Healthcare Facilities |
| Website | https://www.aedifica.eu |
| Audit Risk | 3 |
| Board Risk | 1 |
| Overall Risk | 1 |
| Market Cap | 5.86B |
| Trailing P/E | 6.11 |
| Forward P/E | 12.76 |
| Dividend Rate | 4 |
| Dividend Yield | 5.71% |
| Trailing Annual Div. Rate | 4 |
| Trailing Annual Div. Yield | 5.71% |
| Trailing EPS | 11.49 |
| Forward EPS | 5.51 |
| Book Value | 79.79 |
| Price-to-Book | 0.88 |
| Enterprise-to-Revenue | 29.82 |
| Enterprise-to-EBITDA | 35.42 |
| Ex-Dividend Date | 05/14/2026 |
| Earnings Date | 09/01/2026 |
| Earnings Call Date |